Cellment Cell Attachment Enhancer

Product Description

Maximize Cell Attachment. Improve Transfection Consistency. Increase Viral Vector and Protein Yields.

Product Overview

Cellment™ is a proprietary peptide-based cell attachment enhancer developed by Virongy Biosciences to improve cell adherence and stability during transfection workflows. By strengthening cell attachment prior to transfection, Cellment™ helps reduce cell loss associated with media changes, reagent addition, washing steps, and mechanical handling, resulting in more consistent transfection performance and improved downstream yields.

The Science Behind Cellment

Cellment™ is derived from Virongy’s proprietary Actinator™ peptide platform, a novel class of bioactive peptides engineered from naturally occurring human β-actin sequences.

In a recent publication in Science Advances (Yi et al., 2026), researchers identified a family of actin-derived peptides capable of selectively modulating cytoskeletal dynamics and cell behavior. These peptides were shown to influence multiple actin-dependent cellular processes including:

• Cell attachment and adhesion
• Surface receptor regulation
• Viral vector uptake
• Cellular trafficking and endocytosis
• Cytoskeletal remodeling

Importantly, one member of this peptide family demonstrated a significant enhancement of HEK293T cell-matrix attachment, improving cellular retention following repeated wash steps and mechanical handling. The study also showed that these peptides can modulate actin-associated pathways involved in adhesion and cellular stability.

Cellment™ applies this technology to cell culture workflows where robust cell attachment is critical for successful transfection and vector production.

Published Evidence

In the Science Advances study, treatment with an actinator peptide significantly increased HEK293T cell retention following repeated PBS washes compared to untreated controls, demonstrating enhanced cell-matrix adhesion.

Researchers further observed that actinator peptides:

• Promote cell attachment
• Modulate actin-associated signaling pathways
• Influence adhesion-related cellular functions
• Enhance cellular robustness during handling

These findings suggest that controlled modulation of the actin cytoskeleton can provide practical benefits in cell culture systems where maintaining healthy adherent cells is essential for productivity.

Reference:

Yi F, Guo J, Vo TT, Hetrick B, et al. Discovery of actinators, actin-derived bioactive peptides that modulate cytoskeleton and actin-related cellular activities. Science Advances. 2026;12(16):aeb5548.

Why Cellment™?

During transfection workflows, cell detachment is a common source of variability and reduced productivity. HEK293T cells can become stressed and detach during media exchanges, transfection reagent addition, or extended culture periods, leading to:

• Reduced viable cell density
• Lower transfection efficiency
• Increased experimental variability
• Decreased viral vector and protein yields

Cellment™ addresses these challenges by promoting stronger cell attachment to standard tissue culture-treated surfaces, helping maintain healthy, adherent cultures throughout the transfection process.

Whether you are producing lentivirus, AAV, pseudoviruses, or recombinant proteins, Cellment™ provides a simple and scalable solution to improve culture stability and support reliable manufacturing outcomes.

Key Benefits

• Enhances HEK293T cell attachment prior to transfection
• Reduces cell loss during media changes and handling
• Supports higher viable cell density throughout production
• Improves consistency between transfection experiments
• Compatible with common transfection reagents and protocols
• Easy workflow with no specialized equipment required
• Suitable for research, process development, and production applications

Designed for High-Yield Transfection Workflows

Cellment™ was specifically developed to support applications where maintaining healthy adherent cultures directly impacts productivity.

Ideal Applications

• Lentiviral vector production
• AAV production
• Pseudovirus production
• Recombinant protein expression
• Reporter gene assays
• CRISPR and gene-editing workflows
• Transient plasmid transfection
• Stable cell line development

Researchers routinely invest significant resources optimizing DNA ratios, transfection reagents, and culture conditions. Cellment™ provides an additional optimization strategy by improving one of the most overlooked variables in transfection success: cell attachment stability.

HEK293T Cell Production Benefits

For HEK293T-based production systems, Cellment™ can help:

• Maintain uniform cell monolayers
• Minimize edge effects and localized detachment
• Improve culture robustness during transfection
• Support greater retention of transfected cells
• Increase overall production consistency

By keeping more cells attached and viable throughout the workflow, Cellment™ helps ensure that a larger proportion of the culture contributes to vector or protein production.